Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 24674408)

1.

Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma.

Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):344-8. doi: 10.1016/j.prro.2012.11.001. Epub 2012 Dec 8.

PMID:
24674408
2.

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.

Mundt AJ, Sibley GS, Williams S, Rubin SJ, Heimann R, Halpern H, Weichselbaum RR.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):151-60.

PMID:
8083108
3.

Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):581-6. doi: 10.1016/j.ijrobp.2011.07.035. Epub 2011 Dec 2.

PMID:
22137021
4.
5.

Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy.

Mogavero GT, Jones B, Cameron JL, Coleman J.

AJR Am J Roentgenol. 1992 Nov;159(5):1001-3.

PMID:
1329453
6.

Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.

Cancer J. 2006 Mar-Apr;12(2):113-22.

PMID:
16630402
7.

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.

Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):640-5.

PMID:
16751058
8.

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

Crane CH, Macdonald KO, Vauthey JN, Yehuda P, Brown T, Curley S, Wong A, Delclos M, Charnsangavej C, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):969-74.

PMID:
12095564
9.
10.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
11.

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):692-9. Epub 2005 Oct 19.

PMID:
16242257
12.

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.

Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, Knol J, Dawson LA, Pan C, Lawrence TS.

J Clin Oncol. 2005 Dec 1;23(34):8739-47.

13.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1087-92.

PMID:
9392548
14.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
15.

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

Jackson A, Skwarchuk MW, Zelefsky MJ, Cowen DM, Venkatraman ES, Levegrun S, Burman CM, Kutcher GJ, Fuks Z, Liebel SA, Ling CC.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):685-98.

PMID:
11172950
16.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
17.

Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.

Robertson JM, Lawrence TS, Andrews JC, Walker S, Kessler ML, Ensminger WD.

Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):325-30.

PMID:
9069303
18.

Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).

Cozzarini C, Fiorino C, Ceresoli GL, Cattaneo GM, Bolognesi A, Calandrino R, Villa E.

Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):688-94.

PMID:
12573756
19.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.

PMID:
11955742
20.

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

Zwitter M, Kovac V, Smrdel U, Strojan P.

J Thorac Oncol. 2006 Sep;1(7):662-6.

PMID:
17409933
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk